Jan Freark de Boer

2.4k citations

64 papers · 1.8k indexed · h-index 26

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
Surgery top 5%
- Cholesterol and Lipid Metabolism 24
- Pediatric Hepatobiliary Diseases and Treatments 12
- Lipoproteins and Cardiovascular Health 6
Oncology top 5%
- Drug Transport and Resistance Mechanisms 33
Clinical Biochemistry top 5%
Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 18
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 10
Hepatology
- Liver Diseases and Immunity 5

Co-authors: Uwe J.F. Tietge Wijtske Annema Folkert Kuipers Albert K. Groen Vincent W. Bloks Marleen Schonewille Robin P. F. Dullaart Arne Dikkers
Cited by: Endocrinology, Diabetes and Metabolism Surgery Oncology
Journals: Journal of Lipid Research (7 papers)Atherosclerosis (6 papers)Current Opinion in Lipidology (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Jan Freark de Boer

60 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jan Freark de Boer

Since Specialization

Citations

This map shows the geographic impact of Jan Freark de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Freark de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Freark de Boer more than expected).

Fields of papers citing papers by Jan Freark de Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Freark de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Freark de Boer. The network helps show where Jan Freark de Boer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan Freark de Boer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Freark de Boer Line = papers co-authored together Jan Freark de Boer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Back to basics: Bile acids in fat absorption Cell Metabolism ·Folkert Kuipers,Henkjan J. Verkade,Jan Freark de Boer	2026	0
2	One probe fits all: a highly customizable modular RNA in situ hybridization platform expanding the application of SABER DNA probes Development ·Kirill Ustyantsev,Marián Mrva,Filippo Volpe,Jan Freark de Boer,Folkert Kuipers,Stijn Mouton,Eugène Berezikov	2025	0
3	New insights in amino sugar metabolism by the gut microbiome Gut Microbes ·Nicklas Liljestrand,Jan Freark de Boer,Folkert Kuipers,Jingyuan Fu	2025	0
4	Reversal of insulin resistance in people with obesity by lifestyle‐induced weight loss does not impact the proportion of circulating 12α‐hydroxylated bile acids Diabetes Obesity and Metabolism ·Justin Saunders,Kirsten A. Berk,Martijn Koehorst,Matthew S.R. Abbott,Mark Gesen Carroll,Martijn van Faassen,Jan Freark de Boer,Eline S. van der Valk,Elisabeth F. C. van Rossum,Monique T. Mulder,Folkert Kuipers	2024	3
5	Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice EBioMedicine ·Zhixiong Ying,DEMBINSKA Izabela,和弘大串,V M Lariononv,Joost M. Lambooij,Bruno Guigas,Martin Giera,Jan Freark de Boer,Tamer Coşkun,Hongchang Qu,Yanan Wang,Mariëtte R. Boon,Patrick C.N. Rensen,Sander Kooijman	2023	14
6	Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice International Journal of Molecular Sciences ·Tomonori Joko,Theo H. van Dijk,Martijn Koehorst,Rick Havinga,Jan Freark de Boer,Folkert Kuipers,Tim van Zutphen	2023	2
7	Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans Nature Communications ·Analía Jacob,Ιωάννης Κλαψόπουλος,Roelof Ottenhoff,Олена Пелешенко,Monika Svecla,Thomas van Pelt,Vinay Sachdev,عاليه محمد الخياط,Johannes H.M. Levels,Aldo Jongejan,Jan Freark de Boer,Folkert Kuipers,Antoine Rimbert,Giuseppe Danilo Norata,Anke Loregger,Noam Zelcer	2023	23
8	Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70−/− Mice with a Human-like Bile Acid Composition Biomedicines ·Justin Saunders,H. de Vries,Matthew S.R. Abbott,Martijn Koehorst,Niels L. Mulder,Esther Verkade,Miguel Cláudio Queiroz Rêgo,Theo H. van Dijk,Vincent W. Bloks,Rick Havinga,Henkjan J. Verkade,Jan Freark de Boer,Folkert Kuipers	2023	3
9	Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation EMBO Molecular Medicine ·Enchen Zhou,和弘大串,Hiroyuki Nakashima,Rumei Li,Hendrik J.P. van der Zande,Cong Liu,Zhuang Li,Christoph Müller,Franz Bracher,Yassene Mohammed,Jan Freark de Boer,Folkert Kuipers,Bruno Guigas,Christopher K. Glass,Patrick C.N. Rensen,Martin Giera,Yanan Wang	2023	19
10	Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70−/− mice by reducing fat absorption Journal of Lipid Research ·Rumei Li,Justin Saunders,H. de Vries,Matthew S.R. Abbott,Martijn Koehorst,Niels L. Mulder,Yue Zhang,Binotiana M.N.,Vincent W. Bloks,Jingyuan Fu,Henkjan J. Verkade,Jan Freark de Boer,Folkert Kuipers	2021	18
11	Altered bile acid kinetics contribute to postprandial hypoglycaemia after Roux-en-Y gastric bypass surgery International Journal of Obesity ·Jian Gao,Loek J. M. de Heide,Russell N. Fortier,Martijn Koehorst,Tim van Zutphen,Marloes Emous,Martijn van Faassen,Albert K. Groen,N.A.W. van Riel,Jan Freark de Boer,André P. van Beek,Folkert Kuipers	2021	29
12	Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase Cells ·Vinay Sachdev,Madalina Duta-Mare,Melanie Korbelius,Nemanja Vujić,Christina Leopold,Jan Freark de Boer,John E. Shelton,Peter Fickert,Dagmar Kolb,Folkert Kuipers,Branislav Radović,Gregor Gorkiewicz,Dagmar Kratky	2021	11
13	Group IIA Secretory Phospholipase A2 Predicts Graft Failure and Mortality in Renal Transplant Recipients by Mediating Decreased Kidney Function Journal of Clinical Medicine ·Wijtske Annema,Jan Freark de Boer,Arne Dikkers,Anifa Nurhayati,Markus van der Giet,Stephan J. L. Bakker,Uwe J.F. Tietge	2020	3
14	Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion Cell Metabolism ·Lily Jakulj,Theo H. van Dijk,Jan Freark de Boer,Ruud S. Kootte,Marleen Schonewille,Ziwei Tong,Theo Boer,Vincent W. Bloks,Renze Boverhof,Max Nieuwdorp,Ulrich Beuers,Erik S.G. Stroes,Albert K. Groen	2016	116
15	HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels Journal of clinical lipidology ·Wijtske Annema,H. Willemsen,Jan Freark de Boer,Arne Dikkers,Markus van der Giet,Wybe Nieuwland,Anneke C. Muller Kobold,L. Joost van Pelt,Riemer H. J. A. Slart,Iwan C.C. van der Horst,Robin P. F. Dullaart,René A. Tio,Uwe J.F. Tietge	2016	52
16	Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice Journal of Lipid Research ·Arne Dikkers,Wijtske Annema,Jan Freark de Boer,Jahangir Iqbal,M. Mahmood Hussain,誠一鹿野	2014	10
17	The inverse relation of HDL anti‐oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects Obesity ·Robin P. F. Dullaart,Jan Freark de Boer,Wijtske Annema,Uwe J.F. Tietge	2013	25
18	Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus Atherosclerosis ·Douwe J. Mulder,Jan Freark de Boer,Reindert Graaff,Rindert de Vries,Wijtske Annema,Joop D. Lefrandt,Andries J. Smit,Uwe J.F. Tietge,Robin P.F. Dullaart	2011	21
19	Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Niels Nijstad,Jan Freark de Boer,William R. Lagor,Berta Pou Martorell,David Usher,Wijtske Annema,Markus van der Giet,Daniel J. Rader,Uwe J.F. Tietge	2011	32
20	Superoxide anions and hydrogen peroxide inhibit proliferation of activated rat stellate cells and induce different modes of cell death Liver International ·雄三黒川,Rebekka A. Hannivoort,Jan Freark de Boer,Manon Buist‐Homan,Klaas Nico Faber,Han Moshage	2009	33

About Jan Freark de Boer

Jan Freark de Boer is a scholar working on Oncology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (33 papers), Cholesterol and Lipid Metabolism (24 papers), Liver Disease Diagnosis and Treatment (18 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Liver Diseases and Immunity (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (479 citations), Surgery (891 citations) and Oncology (543 citations). Jan Freark de Boer has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Uwe J.F. Tietge, Wijtske Annema, Folkert Kuipers, Albert K. Groen, Vincent W. Bloks, Marleen Schonewille, Robin P. F. Dullaart, Arne Dikkers, Justina C. Wolters and Jan Albert Kuivenhoven. Their work appears in journals such as Journal of Lipid Research, Atherosclerosis, Current Opinion in Lipidology, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact